PortfoliosLab logoPortfoliosLab logo
DVXV vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DVXV vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WEBs Health Care XLV Defined Volatility ETF (DVXV) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DVXV achieves a -3.39% return, which is significantly lower than XBI's 19.74% return.


DVXV

1D
0.86%
1M
0.61%
YTD
-3.39%
6M
-4.00%
1Y
3Y*
5Y*
10Y*

XBI

1D
3.75%
1M
10.89%
YTD
19.74%
6M
15.96%
1Y
77.88%
3Y*
19.92%
5Y*
1.79%
10Y*
11.06%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DVXV vs. XBI - Yearly Performance Comparison


2026 (YTD)2025
DVXV
WEBs Health Care XLV Defined Volatility ETF
-3.39%21.27%
XBI
SPDR S&P Biotech ETF
19.74%41.09%

Correlation

The correlation between DVXV and XBI is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 23, 2025

0.51

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DVXV vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DVXV

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


XBI
XBI Risk / Return Rank: 9090
Overall Rank
XBI Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 8888
Sortino Ratio Rank
XBI Omega Ratio Rank: 8181
Omega Ratio Rank
XBI Calmar Ratio Rank: 9696
Calmar Ratio Rank
XBI Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVXV vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WEBs Health Care XLV Defined Volatility ETF (DVXV) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DVXVXBIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.46

Calmar ratioReturn relative to maximum drawdown

8.05

Martin ratioReturn relative to average drawdown

23.79

DVXV vs. XBI - Sharpe Ratio Comparison


Loading charts...

Drawdowns

DVXV vs. XBI - Drawdown Comparison

The maximum DVXV drawdown since its inception was -14.36%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for DVXV and XBI.


Loading charts...

Drawdown Indicators


DVXVXBIDifference

Max Drawdown

Largest peak-to-trough decline

-14.36%

-63.89%

+49.53%

Max Drawdown (1Y)

Largest decline over 1 year

-9.72%

Max Drawdown (3Y)

Largest decline over 3 years

-32.99%

Max Drawdown (5Y)

Largest decline over 5 years

-54.71%

Max Drawdown (10Y)

Largest decline over 10 years

-63.89%

Current Drawdown

Current decline from peak

-7.98%

-15.61%

+7.63%

Average Drawdown

Average peak-to-trough decline

-4.86%

-20.93%

+16.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.28%

Volatility

DVXV vs. XBI - Volatility Comparison


Loading charts...

Volatility by Period


DVXVXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.97%

Volatility (6M)

Calculated over the trailing 6-month period

21.32%

Volatility (1Y)

Calculated over the trailing 1-year period

21.43%

26.52%

-5.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.43%

32.30%

-10.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.43%

32.04%

-10.61%

DVXV vs. XBI - Expense Ratio Comparison

DVXV has a 0.89% expense ratio, which is higher than XBI's 0.35% expense ratio.


Dividends

DVXV vs. XBI - Dividend Comparison

DVXV has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.40%.


PositionTTM20252024202320222021202020192018201720162015
DVXV
WEBs Health Care XLV Defined Volatility ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF
0.40%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions


DVXV and XBI have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XBI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XBI is cheaper with a 0.35% expense ratio, compared with 0.89% for DVXV.

XBI has the higher dividend yield at 0.40%, compared with 0.00% for DVXV.

DVXV tracks Syntax Defined Volatility XLV Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: WEBs and State Street. Their fees differ too: 0.89% for DVXV and 0.35% for XBI.

Portfolio Optimizer

Find the right allocation for DVXV and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer